Showing results (621-630 of 3,565) with videos related to
Sort By:
Pageof 357
Journal of Thrombosis and Thrombolysis|June 9, 2009
Effect of clopidogrel discontinuation at 1 year after drug eluting stent placement on soluble CD40L, P-selectin and C-reactive protein levels: DECADES (Discontinuation Effect of Clopidogrel After Drug Eluting Stent): a multicenter, open-label studyJoanna J Wykrzykowska, Ascan Warnholtz, Peter de Jaeger, et al.Journal of Thrombosis and Thrombolysis|March 20, 2009
Soluble endothelial protein C receptor levels in healthy populationFiliz Simsek Orhon, Huseyin Ergun, Yonca Egin, et al.Journal of Thrombosis and Thrombolysis|May 30, 2009
Rates of symptomatic venous thromboembolism in US surgical patients: a retrospective administrative database studyAlex C Spyropoulos, Mohammed Hussein, Jay Lin, et al.Journal of Thrombosis and Thrombolysis|June 24, 2009
Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)A Amin, A C Spyropoulos, P Dobesh, et al.Journal of Thrombosis and Thrombolysis|June 26, 2009
Relationship between 24-h air pollution, emergency department admission and diagnosis of acute coronary syndromeGiuseppe Lippi, Massimo Franchini, Martina Montagnana, et al.Journal of Thrombosis and Thrombolysis|June 19, 2009
The role of ethnicity, age and gender in venous thromboembolismMartina Montagnana, Emmanuel J Favaloro, Massimo Franchini, et al.Journal of Thrombosis and Thrombolysis|January 7, 2009
Middle cerebral artery occlusion 25 years after cranial radiation therapy in acromegaly: a case reportP Maffei, I Albano, C Martini, et al.Journal of Thrombosis and Thrombolysis|December 23, 2008
Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practiceTobias Heer, Claus Juenger, Anselm K Gitt, et al.Journal of Thrombosis and Thrombolysis|February 5, 2009
Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trialsGiuseppe De Luca, Marco Valgimigli, Christian Spaulding, et al.Journal of Thrombosis and Thrombolysis|November 6, 2010
Levosimendan reduces plasma cell-free DNA levels in patients with ischemic cardiomyopathyApostolos Zaravinos, Spiros Tzoras, Stavros Apostolakis, et al.Pageof 357